PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Uterine leiomyosarcoma: an updated series.

Abstract The aim of this study was to analyze and compare the clinicopathologic characteristics, treatment, and survival in patients with uterine leiomyosarcoma (ULMS) during the last 10 years in 3 referral academic centers.
PMID
Related Publications

Evaluating prognostic parameters in women with uterine leiomyosarcoma. A clinicopathologic study.

Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases.

Clinical outcomes of women with recurrent or persistent uterine leiomyosarcoma.

The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.

External validation of a prognostic nomogram for overall survival in women with uterine leiomyosarcoma.

Authors

Mayor MeshTerms
Keywords
Journal Title international journal of gynecological cancer : official journal of the international gynecological cancer society
Publication Year Start
%A Rauh-Hain, Jose Alejandro; Oduyebo, Titilope; Diver, Elisabeth J.; Guseh, Stephanie H.; George, Suzanne; Muto, Micheal G.; del Carmen, Marcela G.
%T Uterine leiomyosarcoma: an updated series.
%J International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, vol. 23, no. 6, pp. 1036-1043
%D 07/2013
%V 23
%N 6
%M eng
%B The aim of this study was to analyze and compare the clinicopathologic characteristics, treatment, and survival in patients with uterine leiomyosarcoma (ULMS) during the last 10 years in 3 referral academic centers.
%K Adult, Aged, Aged, 80 and over, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Leiomyosarcoma, Middle Aged, Neoplasm Grading, Neoplasm Staging, Prognosis, Retrospective Studies, Survival Rate, Uterine Neoplasms
%P 1036
%L 1043
%Y 10.1097/IGC.0b013e31829590dc
%W PHY
%G AUTHOR
%R 2013.......23.1036R

@Article{Rauh-Hain2013,
author="Rauh-Hain, Jose Alejandro
and Oduyebo, Titilope
and Diver, Elisabeth J.
and Guseh, Stephanie H.
and George, Suzanne
and Muto, Micheal G.
and del Carmen, Marcela G.",
title="Uterine leiomyosarcoma: an updated series.",
journal="International journal of gynecological cancer : official journal of the International Gynecological Cancer Society",
year="2013",
month="Jul",
volume="23",
number="6",
pages="1036--1043",
keywords="Adult",
keywords="Aged",
keywords="Aged, 80 and over",
keywords="Combined Modality Therapy",
keywords="Female",
keywords="Follow-Up Studies",
keywords="Humans",
keywords="Leiomyosarcoma",
keywords="Middle Aged",
keywords="Neoplasm Grading",
keywords="Neoplasm Staging",
keywords="Prognosis",
keywords="Retrospective Studies",
keywords="Survival Rate",
keywords="Uterine Neoplasms",
abstract="The aim of this study was to analyze and compare the clinicopathologic characteristics, treatment, and survival in patients with uterine leiomyosarcoma (ULMS) during the last 10 years in 3 referral academic centers.",
issn="1525-1438",
doi="10.1097/IGC.0b013e31829590dc",
url="http://www.ncbi.nlm.nih.gov/pubmed/23714705",
language="eng"
}

%0 Journal Article
%T Uterine leiomyosarcoma: an updated series.
%A Rauh-Hain, Jose Alejandro
%A Oduyebo, Titilope
%A Diver, Elisabeth J.
%A Guseh, Stephanie H.
%A George, Suzanne
%A Muto, Micheal G.
%A del Carmen, Marcela G.
%J International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
%D 2013
%8 Jul
%V 23
%N 6
%@ 1525-1438
%G eng
%F Rauh-Hain2013
%X The aim of this study was to analyze and compare the clinicopathologic characteristics, treatment, and survival in patients with uterine leiomyosarcoma (ULMS) during the last 10 years in 3 referral academic centers.
%K Adult
%K Aged
%K Aged, 80 and over
%K Combined Modality Therapy
%K Female
%K Follow-Up Studies
%K Humans
%K Leiomyosarcoma
%K Middle Aged
%K Neoplasm Grading
%K Neoplasm Staging
%K Prognosis
%K Retrospective Studies
%K Survival Rate
%K Uterine Neoplasms
%U http://dx.doi.org/10.1097/IGC.0b013e31829590dc
%U http://www.ncbi.nlm.nih.gov/pubmed/23714705
%P 1036-1043

PT Journal
AU Rauh-Hain, JA
   Oduyebo, T
   Diver, EJ
   Guseh, SH
   George, S
   Muto, MG
   del Carmen, MG
TI Uterine leiomyosarcoma: an updated series.
SO International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
JI Int. J. Gynecol. Cancer
PD Jul
PY 2013
BP 1036
EP 1043
VL 23
IS 6
DI 10.1097/IGC.0b013e31829590dc
LA eng
DE Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Leiomyosarcoma; Middle Aged; Neoplasm Grading; Neoplasm Staging; Prognosis; Retrospective Studies; Survival Rate; Uterine Neoplasms
AB The aim of this study was to analyze and compare the clinicopathologic characteristics, treatment, and survival in patients with uterine leiomyosarcoma (ULMS) during the last 10 years in 3 referral academic centers.
ER

PMID- 23714705
OWN - NLM
STAT- MEDLINE
DA  - 20130626
DCOM- 20140218
IS  - 1525-1438 (Electronic)
IS  - 1048-891X (Linking)
VI  - 23
IP  - 6
DP  - 2013 Jul
TI  - Uterine leiomyosarcoma: an updated series.
PG  - 1036-43
LID - 10.1097/IGC.0b013e31829590dc [doi]
AB  - OBJECTIVE: The aim of this study was to analyze and compare the clinicopathologic
      characteristics, treatment, and survival in patients with uterine leiomyosarcoma 
      (ULMS) during the last 10 years in 3 referral academic centers. METHODS: All
      patients with ULMS who underwent treatment at the participating institutions
      between January 1, 2000, and December 31, 2010, were identified from the tumor
      registry database. In each case, the diagnosis was confirmed by a dedicated
      gynecologic pathologist following postsurgery pathology review. The Kaplan-Meier 
      method was used to generate overall survival (OS) data. Factors predictive of
      outcome were compared using the log-rank test and Cox regression analysis.
      RESULTS: Analysis of 167 women with ULMS with adequate follow-up was performed.
      One hundred twenty-eight patients (77%) were initially managed at the
      participating institutions, and 39 (23%) were referred after initial management
      at a different institution. Ninety-two (55%) had stage I disease, 7 (4%) had
      stage II, 18 (11%) stage III, and 50 (30%) had stage IV disease. The median OS
      for women with stage I was 75 months, for stage II 66 months, stage III 34
      months, and stage IV 20 months (P < 0.001). For patients with early stage (I and 
      II), race, lower grade, smaller tumor size (<11 cm), low number of mitosis
      (<25/10 high-power field [HPF]), lymphovascular space invasion, and presence of
      necrosis were identified as variables with prognostic influence on survival in
      the univariate analysis. A Cox proportional hazards model identified size 11 cm
      or greater (hazard ratio, 5.9; P < 0.001) and mitotic count of 25/10 HPF or
      greater (hazard ratio, 2.3; P = 0.05) as independent predictors of OS. For
      patients with late stage (stage III and IV), race, stage III versus IV, lower
      grade, smaller tumor size (<11 cm), and low number of mitosis (<25/10 HPF) were
      all associated with significantly improved OS. A Cox proportional hazards model
      identified mitotic count of 25/10 HPF or greater (P = 0.01) as independent
      predictor of OS. CONCLUSIONS: In early stage, size of the tumor and number of
      mitosis were associated to survival. In contrast to late stage, only mitotic
      count was associated to survival.
FAU - Rauh-Hain, Jose Alejandro
AU  - Rauh-Hain JA
AD  - Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology,
      Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
FAU - Oduyebo, Titilope
AU  - Oduyebo T
FAU - Diver, Elisabeth J
AU  - Diver EJ
FAU - Guseh, Stephanie H
AU  - Guseh SH
FAU - George, Suzanne
AU  - George S
FAU - Muto, Micheal G
AU  - Muto MG
FAU - del Carmen, Marcela G
AU  - del Carmen MG
LA  - eng
PT  - Journal Article
PT  - Multicenter Study
PL  - United States
TA  - Int J Gynecol Cancer
JT  - International journal of gynecological cancer : official journal of the
      International Gynecological Cancer Society
JID - 9111626
SB  - IM
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Combined Modality Therapy
MH  - Female
MH  - Follow-Up Studies
MH  - Humans
MH  - Leiomyosarcoma/*mortality/pathology/therapy
MH  - Middle Aged
MH  - Neoplasm Grading
MH  - Neoplasm Staging
MH  - Prognosis
MH  - Retrospective Studies
MH  - Survival Rate
MH  - Uterine Neoplasms/*mortality/pathology/therapy
EDAT- 2013/05/30 06:00
MHDA- 2014/02/19 06:00
CRDT- 2013/05/30 06:00
AID - 10.1097/IGC.0b013e31829590dc [doi]
PST - ppublish
SO  - Int J Gynecol Cancer. 2013 Jul;23(6):1036-43. doi: 10.1097/IGC.0b013e31829590dc.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
<b:Source>
<b:Tag>Rauh-Hain2013</b:Tag>
<b:SourceType>ArticleInAPeriodical</b:SourceType>
<b:Year>2013</b:Year>
<b:Month>Jul</b:Month>
<b:PeriodicalName>International journal of gynecological cancer : official journal of the International Gynecological Cancer Society</b:PeriodicalName>
<b:Volume>23</b:Volume>
<b:Issue>6</b:Issue>
<b:Pages>1036-1043</b:Pages>
<b:Author>
<b:Author><b:NameList>
<b:Person><b:Last>Rauh-Hain</b:Last><b:First>Jose</b:First><b:Middle>Alejandro</b:Middle></b:Person>
<b:Person><b:Last>Oduyebo</b:Last><b:First>Titilope</b:First></b:Person>
<b:Person><b:Last>Diver</b:Last><b:First>Elisabeth</b:First><b:Middle>J</b:Middle></b:Person>
<b:Person><b:Last>Guseh</b:Last><b:First>Stephanie</b:First><b:Middle>H</b:Middle></b:Person>
<b:Person><b:Last>George</b:Last><b:First>Suzanne</b:First></b:Person>
<b:Person><b:Last>Muto</b:Last><b:First>Micheal</b:First><b:Middle>G</b:Middle></b:Person>
<b:Person><b:Last>del Carmen</b:Last><b:First>Marcela</b:First><b:Middle>G</b:Middle></b:Person>
</b:NameList></b:Author>
</b:Author>
<b:Title>Uterine leiomyosarcoma: an updated series.</b:Title>
 <b:ShortTitle>Int. J. Gynecol. Cancer</b:ShortTitle>
<b:Comments>The aim of this study was to analyze and compare the clinicopathologic characteristics, treatment, and survival in patients with uterine leiomyosarcoma (ULMS) during the last 10 years in 3 referral academic centers.</b:Comments>
</b:Source>
</b:Sources>